These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24019886)

  • 21. Dysbalance in sympathetic neurotransmitter release and action in cirrhotic rats: impact of exogenous neuropeptide Y.
    Dietrich P; Moleda L; Kees F; Müller M; Straub RH; Hellerbrand C; Wiest R
    J Hepatol; 2013 Feb; 58(2):254-61. PubMed ID: 23041305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The metabolic syndrome in mice overexpressing neuropeptide Y in noradrenergic neurons.
    Ailanen L; Ruohonen ST; Vähätalo LH; Tuomainen K; Eerola K; Salomäki-Myftari H; Röyttä M; Laiho A; Ahotupa M; Gylling H; Savontaus E
    J Endocrinol; 2017 Jul; 234(1):57-72. PubMed ID: 28468933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.
    Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT
    BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential action of hepatic sympathetic neuropeptides: metabolic action of galanin, vascular action of NPY.
    Mundinger TO; Taborsky GJ
    Am J Physiol Endocrinol Metab; 2000 Mar; 278(3):E390-7. PubMed ID: 10710492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The miR-139-5p/peripheral myelin protein 22 axis modulates TGF-β-induced hepatic stellate cell activation and CCl
    He C; Shu B; Zhou Y; Zhang R; Yang X
    Life Sci; 2021 Jul; 276():119294. PubMed ID: 33675896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The importance of the interaction between hepatocyte and hepatic stellate cells in fibrogenesis induced by fatty accumulation.
    Giraudi PJ; Becerra VJ; Marin V; Chavez-Tapia NC; Tiribelli C; Rosso N
    Exp Mol Pathol; 2015 Feb; 98(1):85-92. PubMed ID: 25533546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.
    Pernow J
    Acta Physiol Scand Suppl; 1988; 568():1-56. PubMed ID: 3232527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system.
    Elenkov IJ; Wilder RL; Chrousos GP; Vizi ES
    Pharmacol Rev; 2000 Dec; 52(4):595-638. PubMed ID: 11121511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cirrhotic liver is depleted of docosahexaenoic acid (DHA), a key modulator of NF-κB and TGFβ pathways in hepatic stellate cells.
    Enguita M; Razquin N; Pamplona R; Quiroga J; Prieto J; Fortes P
    Cell Death Dis; 2019 Jan; 10(1):14. PubMed ID: 30622239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hes1, an important gene for activation of hepatic stellate cells, is regulated by Notch1 and TGF-β/BMP signaling.
    Zhang K; Zhang YQ; Ai WB; Hu QT; Zhang QJ; Wan LY; Wang XL; Liu CB; Wu JF
    World J Gastroenterol; 2015 Jan; 21(3):878-87. PubMed ID: 25624721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid measurement of cardiac neuropeptide dynamics by capacitive immunoprobe in the porcine heart.
    Kluge N; Dacey M; Hadaya J; Shivkumar K; Chan SA; Ardell JL; Smith C
    Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H66-H76. PubMed ID: 33095651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endoglin in human liver disease and murine models of liver fibrosis-A protective factor against liver fibrosis.
    Alsamman M; Sterzer V; Meurer SK; Sahin H; Schaeper U; Kuscuoglu D; Strnad P; Weiskirchen R; Trautwein C; Scholten D
    Liver Int; 2018 May; 38(5):858-867. PubMed ID: 28941022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease.
    Kimura T; Singh S; Tanaka N; Umemura T
    Front Endocrinol (Lausanne); 2021; 12():773432. PubMed ID: 34938271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Propranolol, a β-adrenoceptor antagonist, worsens liver injury in a model of non-alcoholic steatohepatitis.
    McKee C; Soeda J; Asilmaz E; Sigalla B; Morgan M; Sinelli N; Roskams T; Oben JA
    Biochem Biophys Res Commun; 2013 Aug; 437(4):597-602. PubMed ID: 23850676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adrenergic and non-adrenergic mechanisms in sympathetic vascular control of the nasal mucosa.
    Lacroix JS
    Acta Physiol Scand Suppl; 1989; 581():1-63. PubMed ID: 2568728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis.
    Lakner AM; Steuerwald NM; Walling TL; Ghosh S; Li T; McKillop IH; Russo MW; Bonkovsky HL; Schrum LW
    Hepatology; 2012 Jul; 56(1):300-10. PubMed ID: 22278637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proline-rich tyrosine kinase 2 mediates transforming growth factor-beta-induced hepatic stellate cell activation and liver fibrosis.
    Kim J; Kang W; Kang SH; Park SH; Kim JY; Yang S; Ha SY; Paik YH
    Sci Rep; 2020 Dec; 10(1):21018. PubMed ID: 33273492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis.
    Barcena-Varela M; Paish H; Alvarez L; Uriarte I; Latasa MU; Santamaria E; Recalde M; Garate M; Claveria A; Colyn L; Arechederra M; Iraburu MJ; Milkiewicz M; Milkiewicz P; Sangro B; Robinson SM; French J; Pardo-Saganta A; Oyarzabal J; Prosper F; Rombouts K; Oakley F; Mann J; Berasain C; Avila MA; G Fernandez-Barrena M
    Gut; 2021 Feb; 70(2):388-400. PubMed ID: 32327527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Norepinephrine release in the immature ovary is regulated by autoreceptors and neuropeptide-Y.
    Ferruz J; Ahmed CE; Ojeda SR; Lara HE
    Endocrinology; 1992 Mar; 130(3):1345-51. PubMed ID: 1537296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of EGFR attenuates fibrosis and stellate cell activation in diet-induced model of nonalcoholic fatty liver disease.
    Liang D; Chen H; Zhao L; Zhang W; Hu J; Liu Z; Zhong P; Wang W; Wang J; Liang G
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):133-142. PubMed ID: 29038049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.